新诊断的多发性骨髓瘤患者的结果与同时或之前的固体瘤病史
Yaşa Gül Mutlu1, Şerife Emre Ünsal2, Buse Güleç3
1Department of Hematology, Gaziantep City Hospital, Gaziantep, Turkey.
Clinical lymphoma, myeloma & leukemia
|November 8, 2025
概括
新诊断多发性骨髓瘤 (NDMM) 和同步固体瘤的患者表现出更高的外骨髓性疾病率. 同步和先前固体瘤组之间的生存结果相似,表明需要量身定制的治疗.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 临床医学 临床医学
背景情况:
- 固体瘤和多发性骨髓瘤 (MM) 的共存带来了诊断和治疗方面的挑战.
- 关于固体瘤和MM患者的临床结果的数据有限.
- 这项研究涉及新诊断多发性骨髓瘤 (NDMM) 患者的临床特征和生存率,这些患者具有同步或先前的固体瘤.
研究的目的:
- 评估临床特征和生存结果.
- 为了比较同步与先前固体瘤患者之间的结果.
- 为了确定管理患有并发性恶性瘤的患者的挑战.
主要方法:
- 对41名具有固体瘤病史的NDMM患者进行了回顾性分析.
- 被归类为同步 (在6个月内) 或之前的患者.
- 临床特征,治疗模式和结果的评估,按实体瘤诊断时间分层.
主要成果:
- 常见的固体瘤包括乳腺,肺,结肠和前列腺癌.
- 在同步组中,100%的患者患有外骨髓性疾病,而在先前组中,这一比例为0%.
- 在同步和先前固体瘤组之间,整体存活率 (中位数为48个月) 没有显著差异.
结论:
- 在NDMM患者中,同步固体瘤与增加的外骨髓性疾病相关.
- 临床决策可能会受到并发的固体瘤的影响,需要多学科护理.
- 对MM的外骨参与要求对并存的固体恶性瘤进行调查.
更多相关视频
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
13.5K
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
9.1K
相关概念视频
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
